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ABSTRACT The RNA polymerase (RNAP) binding protein A (RbpA) contributes to the
formation of stable RNAP-promoter open complexes (RPo) and is essential for viability in
mycobacteria. Four domains have been identified in the RbpA protein, i.e., an N-terminal
tail (NTT) that interacts with RNAP = and  subunits, a core domain (CD) that contacts
the RNAP = subunit, a basic linker (BL) that binds DNA, and a -interaction domain
(SID) that binds group I and group II  factors. Limited in vivo studies have been per-
formed in mycobacteria, however, and how individual structural domains of RbpA con-
tribute to RbpA function and mycobacterial gene expression remains mostly unknown.
We investigated the roles of the RbpA structural domains in mycobacteria using a panel
of rbpA mutants that target individual RbpA domains. The function of each RbpA do-
main was required for Mycobacterium tuberculosis viability and optimal growth in Myco-
bacterium smegmatis. We determined that the RbpA SID is both necessary and sufficient
for RbpA interaction with the RNAP, indicating that the primary functions of the NTT
and CD are not solely association with the RNAP. We show that the RbpA BL and SID
are required for RPo stabilization in vitro, while the NTT and CD antagonize this activity.
Finally, RNA-sequencing analyses suggest that the NTT and CD broadly activate gene
expression, whereas the BL and SID activate or repress gene expression in a gene-
dependent manner for a subset of mycobacterial genes. Our findings highlight spe-
cific outcomes for the activities of the individual functional domains in RbpA.
IMPORTANCE Mycobacterium tuberculosis is the causative agent of tuberculosis and
continues to be the most lethal infectious disease worldwide. Improved molecular
understanding of the essential proteins involved in M. tuberculosis transcription, such
as RbpA, could provide targets for much needed future therapeutic agents aimed at
combatting this pathogen. In this study, we expand our understanding of RbpA by
identifying the RbpA structural domains responsible for the interaction of RbpA with
the RNAP and the effects of RbpA on transcription initiation and gene expression.
These experiments expand our knowledge of RbpA while also broadening our un-
derstanding of bacterial transcription in general.
KEYWORDS Mycobacterium, RNA polymerases, RbpA, eubacteria, transcription,
transcriptional regulation
Progress toward the World Health Organization (WHO) goal of eradicating Mycobac-terium tuberculosis continues to be hampered by the estimated 480,000 new cases
of multidrug-resistant M. tuberculosis infections among the overall 10.1 million new
cases of tuberculosis worldwide in 2016 (1). Strategies for M. tuberculosis eradication
include the development of novel therapies, which is aided by the identification of
druggable targets. Bacterial transcription is carried out by the RNA polymerase (RNAP)
Received 15 November 2017 Accepted 18
April 2018
Accepted manuscript posted online 23
April 2018
Citation Prusa J, Jensen D, Santiago-Collazo G,
Pope SS, Garner AL, Miller JJ, Ruiz Manzano A,
Galburt EA, Stallings CL. 2018. Domains within
RbpA serve specific functional roles that
regulate the expression of distinct
mycobacterial gene subsets. J Bacteriol
200:e00690-17. https://doi.org/10.1128/JB
.00690-17.
Editor Tina M. Henkin, Ohio State University
Copyright © 2018 American Society for
Microbiology. All Rights Reserved.




July 2018 Volume 200 Issue 13 e00690-17 jb.asm.org 1Journal of Bacteriology
 on O










and has been successfully targeted using rifampin, which remains a cornerstone of
therapy for M. tuberculosis patients (2, 3). In addition to the subunits that constitute the
RNAP holoenzyme in all bacteria (two  subunits and , =, , and  subunits),
mycobacteria also require two additional essential proteins, RNAP binding protein A
(RbpA) and CarD, to form stable transcription initiation complexes (4–7). Unlike Esch-
erichia coli, which has been used to define the events of bacterial transcription
initiation, mycobacteria are unable to irreversibly form stable RNAP-promoter open
complexes (RPo) and require both RbpA and CarD to reach RPo stability comparable to
that of E. coli (4, 7, 8), which could explain the essentiality of these proteins (9–11). Both
CarD and RbpA have also been shown to affect the sensitivity of mycobacteria to
rifampin (12, 13). Therefore, improving our understanding of these transcription factors
could provide an avenue to future therapies targeting CarD or RbpA while improving
the efficacy of currently approved drugs.
RbpA was discovered in Streptomyces coelicolor as a protein that coimmunoprecipi-
tates with the RNAP and is unique to the Actinobacteria phylum (14). RbpA consists of
a central core domain (CD) flanked by an unstructured 26-amino-acid N-terminal tail
(NTT) and a C-terminal -interaction domain (SID) linked to the CD by a 15-amino-acid
basic linker (BL) (6, 11, 15, 16). The RbpA SID forms a stable binary complex with group
I (A in M. tuberculosis) and certain group II (B in M. tuberculosis)  factors (6, 14–16).
Bacterial two-hybrid experiments in S. coelicolor showed that mutating the R88 residue
within the RbpA SID to an alanine significantly weakened the interaction between S.
coelicolor RbpA and the housekeeping HrdB (15), highlighting the importance of this
residue in the interaction. Based on structural studies, the BL makes electrostatic
contacts with the DNA phosphate backbone of the nontemplate strand upstream of the
10 promoter element in the RPo conformation, the CD is positioned near the RNAP =
zinc binding domain, and the NTT threads into the RNAP active site cleft between the
= zinc binding domain and the A4 domain (6, 16, 17). In support of a functional role
for the BL, fluorescence anisotropy experiments showed that addition of M. tuberculosis
RbpA to Mycobacterium bovis RNAP-A holoenzyme in the presence of M. tuberculosis
CarD decreased the dissociation constant (Kd) of RNAP binding to a vapB10 promoter
template and an R79A mutation in the M. tuberculosis RbpA BL abolished the RbpA-
mediated increases in RNAP affinity for the vapB10 promoter (16).
Most characterization of RbpA has been performed in vitro, and there have been
only limited studies of how the domains of RbpA contribute to gene regulation in
mycobacteria. In a recent study using Mycobacterium smegmatis, an R79A mutation in
the RbpA BL and deletion of the NTT and CD resulted in slower growth of the bacteria
(6). Herein, we expand on that work and compare the roles of each RbpA domain, both
in vitro and in vivo, to show that only the SID is required for association with the RNAP
and the activities of different domains affect the expression of distinct gene sets in the
bacteria.
RESULTS
Individual RbpA structural domains are important for mycobacterial growth
and viability. To distinguish the roles of the RbpA structural domains in mycobacteria
(Fig. 1A), we first engineered merodiploid strains of M. tuberculosis and M. smegmatis
that expressed rbpAMtb at the chromosomal attB site. The M. smegmatis and M.
tuberculosis RbpA proteins are 92% identical. Expression of rbpAMtb at the attB site
allowed deletion of the endogenous rbpA gene in both M. tuberculosis and M. smeg-
matis, demonstrating that the RbpA protein from M. tuberculosis can substitute for the
M. smegmatis RbpA protein to support viability. We then attempted to replace the
rbpAMtb gene at the attB site in M. tuberculosis and M. smegmatis with alleles encoding
RbpAMtbR79A, RbpAMtbR88A, RbpAMtb1–71, or RbpAMtb72–111, using a previously described
gene-swapping method (13, 18). The R79A mutation is within the BL and should disrupt
DNA binding, the R88A mutation in the SID has been shown to weaken the affinity of
RbpA for , the position 1 to 71 RbpA fragment is deleted for the BL and SID, and the
position 72 to 111 RbpA fragment is deleted for the NTT and CD (Fig. 1) (11, 15, 16).
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Using the gene-swapping approach, we found that none of the RbpA mutants could
support viability in M. tuberculosis (Fig. 1B), demonstrating that M. tuberculosis is highly
sensitive to any kind of disruption in RbpA function. In contrast, all of the mutant rbpA
alleles except that encoding RbpAMtb1–71 supported viability of M. smegmatis, thus
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FIG 1 Multiple RbpA structural domains are important for mycobacterial growth and viability. (A) Diagram showing
that M. tuberculosis RbpA is composed of an N-terminal tail (NTT) (amino acids 1 to 25), a core domain (CD) (amino
acids 26 to 66), a basic linker (BL) (amino acids 67 to 80), and a -interaction domain (SID) (amino acids 81 to 111).
(B) Table of M. tuberculosis and M. smegmatis strains engineered or determined to be nonviable with replacement
of the RbpAMtbWT expression cassette with a cassette expressing RbpAMtbR79A, RbpAMtbR88A, RbpAMtb1–71, or
RbpAMtb72–111. An empty expression cassette was transformed as a negative control, while replacement of
RbpAMtbWT with RbpAMtbWT was used as a positive control. (C) Growth curves of M. smegmatis expressing
RbpAMtbWT, RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111, with nine replicates for each strain. (D) M. smegmatis
doubling times calculated from the growth curves in panel C. Results are plotted as means  standard deviations.
Statistical significance was analyzed by analysis of variance (ANOVA) and Tukey’s multiple-comparison test. *, P 
0.05; **, P  0.01; ***, P  0.001. All comparisons were included in the analysis, but only statistically significant
differences are indicated in the figure. (E) Lysates from M. smegmatis ΔrbpA attB::tet-rbpA expressing RbpAMtbWT-
FLAG (lane 1), RbpAMtbR79A-FLAG (lane 2), RbpAMtbR88A-FLAG (lane 3), or RbpAMtb72–111-FLAG (lane 4), analyzed with
monoclonal antibodies specific for either RNAP  or FLAG. (F) Graphical representation of RbpA stability as the ratio
of RbpA molecules per RNAP , showing the means  standard errors of the means of three replicates. Statistical
significance was analyzed by ANOVA and Tukey’s multiple-comparison test. *, P  0.05; ns, not significant.
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providing us with a genetic system to study M. tuberculosis RbpA in vivo by using M.
smegmatis strains expressing RbpAMtbWT, RbpAMtbR79A, RbpAMtbR88A, and RbpAMtb72–111.
The inability to obtain strains expressing the RbpAMtb1–71 allele as the only rbpA allele
demonstrated that the RbpA BL and SID are required for viability in mycobacteria.
To determine how each of these mutations in RbpA affected mycobacterial growth,
the doubling times of M. smegmatis strains expressing the wild type (WT), RbpAMtbWT,
or mutant RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111 were measured (Fig. 1C and D).
The doubling times of the RbpAMtbR79A (4.3 h) and RbpAMtbR88A (4.4 h) strains were
significantly longer than that of the RbpAMtbWT strain (3.2 h), indicating that the
functions performed by the RbpA BL and SID are required for optimal M. smegmatis
growth (Fig. 1D). Although the growth rate of the RbpAMtb72–111 (3.9 h) strain trended
lower than that of the RbpAMtbWT strain, this difference was not statistically significant,
indicating that loss of the RbpA NTT and CD has only a mild effect on M. smegmatis
growth.
To determine whether the mutations in RbpA affected the RbpA protein levels in M.
smegmatis, we engineered M. smegmatis strains that expressed the C-terminally FLAG-
tagged RbpA proteins RbpAMtbWT-FLAG, RbpAMtbR79A-FLAG, RbpAMtbR88A-FLAG, and
RbpAMtb72–111-FLAG as the only copy of the rbpA product and we measured the levels
of RbpAMtbWT-FLAG, RbpAMtbR79-FLAG, RbpAMtbR88A-FLAG, and RbpAMtb72–111-FLAG
proteins in cell lysates by Western blot analysis (Fig. 1E). The levels of RbpAMtbR88A-FLAG
protein were significantly lower than the levels of RbpAMtbWT-FLAG. Therefore, the
slower growth of the M. smegmatis strain expressing RbpAMtbR88A could in part be a
result of lower levels of RbpA protein. The levels of RbpAMtb72–111-FLAG protein were
also significantly lower in cell lysates, compared to the levels of RbpAMtbWT-FLAG.
However, we found that this decrease in band intensity was due to issues with the
detection of RbpAMtb72–111-FLAG with the anti-FLAG antibody. Therefore, it is unclear
whether deletion of the RbpA NTT and CD decreases the levels of RbpAMtb72–111-FLAG
in cell lysates.
The RbpA SID is necessary and sufficient for association with RNAP. Structural
studies indicate that RbpA engages in four different macromolecular interactions in
mycobacterial RNAP-promoter initiation complexes, i.e., (i) the RbpA NTT binding to
RNAP = and , (ii) the RbpA CD binding to RNAP =, (iii) the RbpA BL binding to DNA,
and (iv) the RbpA SID binding to  (6, 11, 16); however, it is not known which of these
interactions are required for the association of RbpA with the RNAP. To address this gap
in knowledge, we performed coimmunoprecipitation experiments analyzing the
amounts of A, B, and RNAP  subunit that coimmunoprecipitated with the RbpA-
FLAG-tagged proteins (Fig. 2). The levels of A and B coimmunoprecipitated with
RbpAMtbR88A-FLAG were dramatically reduced, compared to those coimmunoprecipi-
tated with RbpAMtbWT-FLAG (Fig. 2A, B, and C), as expected based on the importance
of R88 for  binding (15). In addition to the decreases in A and B levels, the levels of
RNAP  coimmunoprecipitated with RbpAMtbR88A-FLAG were significantly reduced (Fig.
2A and D). In crystallographic studies, the R88 in the RbpA SID is not positioned to bind
directly to the core RNAP subunits; therefore, we conclude that the reduced  coim-
munoprecipitated with RbpAMtbR88A-FLAG is due to the reduced RbpA- interaction.
This indicates that the interaction between the RbpA SID and the  subunit is the
primary determinant of the association of RbpA with the RNAP. In contrast, deletion of
the NTT and CD (RbpAMtb72–111) did not decrease the amounts of RNAP , A, or B
associated with RbpA. Therefore, despite the observations that the CD was positioned
to interact with RNAP = and the NTT was positioned to interact with RNAP = and 
(6, 17), these interactions are not necessary for association with RNAP. Notably, al-
though the levels of RNAP , A, and B coimmunoprecipitated per molecule of
RbpAMtb72–111 appear to be increased in Fig. 2, we found that the differences were due
to lower levels of RbpAMtb72–111 detection by Western blot analysis (data not shown).
RbpAMtbR79A-FLAG coimmunoprecipitated similar levels of  and A, compared to
RbpAMtbWT-FLAG. Coimmunoprecipitated levels of B trended higher with RbpAMtbR79A-
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FLAG but were not statistically significantly different from those observed with
RbpAMtbWT-FLAG (Fig. 2). Collectively, our data show that the RbpA SID is both
necessary and sufficient for interaction with RNAP.
RbpA mutants exhibit distinct kinetic phenotypes on the pathway to RPo
formation. RbpA has been proposed to accelerate a forward kinetic step in the
formation of RPo, resulting in more stable RPo at equilibrium (6, 7). A real-time
fluorescence assay (7) was used to determine the effects of RbpA mutants on RPo
formation by the M. tuberculosis RNAP. Briefly, a Cy3 label was incorporated onto the
2 dT nucleotide, with respect to the 1 transcription start site, of the nontemplate
strand of the M. tuberculosis rRNA rrnAP3 promoter (19). The Cy3 label is positioned
within the transcription bubble such that, upon opening of the promoter DNA, a 2-fold
fluorescence enhancement is observed (20); this allows quantitation of the kinetics of
RPo equilibration, by monitoring the change in fluorescence as a function of time, and
the stability of RPo, by using the equilibrium fluorescence value (4, 7, 21). Incubating
RbpAMtbWT at a saturating concentration (2 M) with 35 nM M. tuberculosis RNAP-A
holoenzyme and the Cy3-labeled rrnAP3 promoter resulted in a greater amount of RPo
at equilibrium than observed with RNAP-A holoenzyme and the rrnAP3 promoter
alone (Fig. 3A), consistent with the known role of RbpA in stabilizing the otherwise
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FIG 2 The RbpA SID is necessary and sufficient for the association of RbpA with the RNAP. (A) Western blot analysis
of lysates immunoprecipitated for FLAG-tagged RbpA. Monoclonal antibodies specific for FLAG were used to detect
RbpAMtb-FLAG protein variants (bottom row). RNAP  coimmunoprecipitated by the FLAG-tagged RbpA constructs
was detected with a monoclonal antibody specific for RNAP , and both A and B were detected using a
monoclonal antibody specific for a shared epitope in E. coli 70. (B to D) Amounts of A (B), B (C), and RNAP  (D)
coimmunoprecipitated by RbpA, based on band intensity, and expressed as the ratio of A, B, or RNAP  to RbpA,
with eight replicates for each strain. Results are shown as means  standard deviations. Statistical significance was
determined by one-way ANOVA and Kruskal-Wallis multiple-comparison test. *, P  0.05; **, P  0.01.
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RbpAMtbR79A and RbpAMtbR88A were added, no enhancement of the amount of RPo at
equilibrium over RNAP-A holoenzyme and the rrnAP3 promoter alone was observed
(Fig. 3A and B), demonstrating the importance of these residues. For a qualitative
description of the kinetics, we calculated t1/2 values (the time required to reach the
midpoint of the final equilibrium fluorescence). Interestingly, these mutants exhibited
approximately 3-fold faster kinetics (RbpAMtbR79A t1/2 of 14.8  1.1 s and RbpAMtbR88A
t1/2 of 16.4  1.1 s), compared with the RNAP-A holoenzyme and the rrnAP3 promoter
alone (t1/2 of 43  2 s) (Fig. 3C). The finding of faster kinetics accompanied by no
change in the equilibrium fluorescence value suggests that these mutants retain the
ability to stabilize the transition state on the pathway to RPo but have lost the ability
to stabilize RPo itself. This behavior is analogous to the classic model for enzyme activity
(22), in which the transformation of substrate to product is accelerated without changes
in the final equilibrium between the two states. In this scenario, the mutant RbpA
proteins may increase the rate of opening and the rate of closing equally, such that the
ratio of rates remains constant. These results suggest that the interactions between
RbpA and both the promoter DNA (R79) and  factor (R88) are essential for RPo
stabilization and that RbpA is still capable of catalyzing promoter opening even in the









































































































































































FIG 3 RbpA mutants exhibit distinct effects on RPo formation. (A) Fluorescence fold changes, compared to
DNA alone, which were was used to monitor RPo formation and stability in real time, using fixed amounts
of M. tuberculosis RNAP (35 nM), Cy3-labeled (2 thymine nontemplate strand) M. tuberculosis rrnAP3
promoter DNA (1 nM), and RbpA (2 M). Time courses are shown as an average of at least 5 replicates. (B)
Total fluorescent fold changes, normalized to RNAP-A-rrnAP3 alone, for all RbpA constructs. (C) t1/2 values,
calculated as the time required to reach one-half of the final fluorescence intensity, for each sample. For
panels B and C, means  standard errors of the means are plotted. Statistical significance was analyzed by
ANOVA and Tukey’s multiple-comparison test. *, P  0.05; **, P  0.01; ****, P  0.0001; ns, not significant.
Only comparisons between RbpAWT and each of the RbpA mutant constructs are shown in the figure.
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To further investigate the domain requirements for RPo stabilization, we repeated
the experiments described above with RbpAMtb1–71 (containing the NTT and CD) and
RbpAMtb26 –71 (containing the CD only), and we observed minimal enhancement in RPo
stability (Fig. 3A and B) and an identical rate of RPo equilibration (t1/2 of 42  3 s),
relative to the RNAP-A holoenzyme and the rrnAP3 promoter alone (Fig. 3A and C),
indicating that the NTT and CD are unable to affect RPo stability on their own.
Conversely, RbpAMtb72–111 showed the greatest amount of RPo at equilibrium, even
higher than that of RbpAMtbWT (Fig. 3A and B), with kinetics (t1/2 of 7.8  0.9 s) similar
to those of RbpAMtbWT (t1/2 of 6.9  0.5 s) (Fig. 3C). The finding that RbpAMtb72–111
exhibits similar kinetics but a greater amount of RPo at equilibrium, compared with
RbpAMtbWT, raises the possibility that the NTT and CD negatively affect RbpA activity
under these conditions. To determine whether it was the NTT and/or the CD that
antagonized RbpA-mediated RPo stabilization, we assayed an RbpA protein with dele-
tion of just the NTT (RbpAMtb26 –111). RbpAMtb26 –111 yielded a greater fold change in
fluorescence than did RbpAMtbWT but smaller change than did RbpAMtb72–111 (Fig. 3A
and B), suggesting that both the CD and NTT are responsible for the antagonistic effect
on RbpA-dependent RPo stability. RbpAMtb26 –111 exhibited approximately 2-fold slower
kinetics of RPo equilibration (t1/2 of 17.6  1.2 s) than did RbpAMtb72–111 (t1/2 of 7.8 
0.9 s) and RbpAMtbWT (t1/2 of 6.9  0.5 s) (Fig. 3A and C). One possibility consistent with
this observation is that, in the presence of the rest of the domains, the NTT decreases
the amount of RPo at equilibrium by increasing a reverse rate leading toward the
RNAP-promoter closed complex (RPc). Importantly, performing these experiments with
multiple RNAP concentrations suggests that the effect of each RbpA construct is limited
by DNA-bound kinetic intermediates and not the rates of association and dissociation
of RNAP to and from promoter DNA (see Fig. S1 in the supplemental material). Taken
together, these results suggest that residues R79 and R88 are essential for RPo stabili-
zation and that the NTT and CD can inhibit RPo formation.
Truncation of the RbpA NTT/CD and mutations in the RbpA BL and SID result
in distinct gene expression changes in M. smegmatis. To determine how the individual
RbpA domains contribute to gene expression, we performed RNA-sequencing (RNA-seq)
experiments with cultures of M. smegmatis expressing RbpAMtbR79A, RbpAMtbR88A,
RbpAMtb72–111, or RbpAMtbWT (Table S1). The only previous analysis of this type focused
on the gene expression profiles that resulted from deletion of the RbpA NTT and CD in
M. smegmatis, but it did not investigate the roles of the other RbpA domains (6).
Principal-component analysis (PCA) of the RNA-seq data was performed and provided
a general overview of how gene expression patterns among the RbpA mutants
clustered in relationship to each other. Three distinct sample clusters were apparent
from the PCA results (Fig. 4A), indicating three different gene expression patterns. The
first cluster included the three RbpAMtbWT replicates, the second cluster included the
three RbpAMtb72–111 replicates, and the third cluster included the replicates from both
RbpAMtbR79A and RbpAMtbR88A. The PCA results indicate that loss of the RbpA NTT/CD
affects a gene subset that is different from the genes affected by mutations in the RbpA
BL and SID. The number of genes significantly (adjusted P values of 0.05) upregulated
or downregulated 2-fold in the RbpA mutants varied, with 766 genes being differen-
tially expressed in RbpAMtb72–111, compared to 199 genes in RbpAMtbR79A and 244
genes in RbpAMtbR88A (Fig. 4B; also see Table S2).
Consistent with the PCA results, there was significant overlap in upregulated and
downregulated genes between the RbpAMtbR79A and RbpAMtbR88A strains (Fig. 4C and
D and Table 1), indicating that the SID and BL perform functions that contribute to the
expression of a common subset of M. smegmatis genes. Also consistent with the PCA
results, the upregulated and downregulated genes in RbpAMtb72–111 had little overlap
with those in either RbpAMtbR79A or RbpAMtbR88A (Fig. 4C and D). Therefore, the number
of shared downregulated or upregulated genes between RbpAMtb72–111 and either
RbpAMtbR79A or RbpAMtbR88A was underenriched (Table 1).
Given that RbpA stabilizes RNAP-A-rrnAP3 RPo in vitro and the R79 and R88 residues
are essential for this activity, it might be expected that the RbpA BL and SID cooperate
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to activate transcription from all promoters that RbpA regulates. Similarly, the ability of
the NTT and CD to antagonize RbpA-mediated RPo stabilization would lead to the
hypothesis that expression from RbpA-regulated genes would be increased in their
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FIG 4 Truncation of the RbpA NTT/CD and mutations in the RbpA BL and SID result in distinct gene expression
changes in M. smegmatis. (A) PCA results showing sample distances across two principal components (PC),
generated using read counts of RNA collected from M. smegmatis expressing RbpAMtbWT, RbpAMtbR79A, RbpAMtbR88A,
or RbpAMtb72–111, mapped to the M. smegmatis mc2155 genome and normalized with regularized logarithmic
transformation. Each point represents one of three replicates for RbpAMtbWT, RbpAMtbR79A, RbpAMtbR88A, and
RbpAMtb72–111. (B) Numbers of genes significantly (adjusted P values of 0.05) upregulated or downregulated 2-fold
in M. smegmatis expressing RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111, relative to M. smegmatis expressing
RbpAMtbWT. FC, fold change. (C) Venn diagram showing overlap of the genes downregulated 2-fold (adjusted P
values of 0.05) in M. smegmatis expressing RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111, relative to M. smegmatis
expressing RbpAMtbWT. (D) Venn diagram showing overlap of the genes upregulated 2-fold (adjusted P values of
0.05) in M. smegmatis expressing RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111, relative to M. smegmatis expressing
RbpAMtbWT. (E) qRT-PCR and RNA-seq log2 fold changes for 16 genes in M. smegmatis expressing RbpAMtbR79A,
RbpAMtbR88A, or RbpAMtb72–111, relative to M. smegmatis expressing RbpAMtbWT. Transcript levels were normalized to
an MS2 RNA spike-in control that was added at a constant level of 1 ng/1 billion cells. Means  standard errors of
the means of three replicates are shown for each M. smegmatis strain.
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numbers of transcripts were upregulated and downregulated in each RbpA mutant
(Fig. 4B). These data could mean that domains within RbpA can promote both activa-
tion and repression of gene expression. However, it is also possible that there was
general downregulation or upregulation of gene expression in the RbpA mutants that
we were unable to detect due to the addition of equal amounts of RNA from each strain
into the sequencing reaction. To explore this possibility, we performed spike-in exper-
iments (23) in which we isolated RNA from cultures of M. smegmatis expressing
RbpAMtbR79A, RbpAMtbR88A, RbpAMtb72–111, or RbpAMtbWT and added 1 ng of MS2
bacteriophage RNA (Roche) per 1 billion bacterial cells to the RNA samples. cDNA was
generated for each sample, and quantitative reverse transcription-PCR (qRT-PCR) was
performed to determine transcript levels for 16 M. smegmatis genes relative to MS2
RNA, which was used as a proxy to represent cell number. The 16 M. smegmatis genes
analyzed included genes that were significantly upregulated or downregulated in RbpA
mutants during RNA-seq experiments. When results were normalized to MS2 RNA
levels, all 16 genes, including the genes considered highly upregulated in the RNA-seq
analysis, were downregulated in RbpAMtb72–111 compared to RbpAMtbWT, suggesting
that overall transcript levels in RbpAMtb72–111 are decreased (Fig. 4E). Therefore, despite
the findings that deletion of the NTT and CD had only a mild effect on the growth rate
(Fig. 1C and D) and enhanced RPo stabilization activity in vitro (Fig. 3A and B), the NTT
and CD are required for WT levels of gene expression in M. smegmatis. In contrast,
qRT-PCR results for the RbpAMtbR79A and RbpAMtbR88A mutants were similar to the
RNA-seq results, indicating that RbpAMtbR79A and RbpAMtbR88A mutants do indeed lead
to both upregulation and downregulation of gene expression. When we analyzed the
genes that were most upregulated or downregulated with the RbpAMtbR79A and
RbpAMtbR88A mutants, they fell into multiple diverse functional classes (Table S2),
indicating that RbpA activity likely affects multiple cellular processes.
DISCUSSION
In this study, we investigated the functions of the individual RbpA structural
domains to gain insight into the complex in vivo roles of RbpA. To study the roles of the
RbpA NTT and CD, we truncated the N-terminal 71 amino acids of RbpA. The role of the
RbpA BL was probed using a point mutation at R79, which has been implicated in
the interaction between RbpA and DNA (16). Finally, we investigated the RbpA SID by
using a point mutation at R88, which is one of the key residues needed for the
interaction between RbpA and  (15) but had yet to be studied in mycobacteria in vivo.
We found that the function of each RbpA structural domain is required for M. tuber-
culosis viability and wild-type growth rates in M. smegmatis and disruption of the RbpA
BL and SID functions causes a more severe growth defect than loss of the NTT and CD.
TABLE 1 Overlap enrichment of differentially expressed genes in M. smegmatis strains
expressing RbpAMtbR79A, RbpAMtbR88A, or RbpAMtb72–111a
Overlap comparison Hypergeometric P value Fold enrichment
RbpAMtbR79A vs RbpAMtbR88A, upregulated 1.81E11 1.52
RbpAMtbR79A vs RbpAMtbR88A, downregulated 0.0003 1.59
RbpAMtbR79A vs RbpAMtb72–111, upregulated 0.094 1.22
RbpAMtbR79A vs RbpAMtb72–111, downregulated 1.63E07 2.03
RbpAMtbR88A vs RbpAMtb72–111, upregulated 0.001 1.43
RbpAMtbR88A vs RbpAMtb72–111, downregulated 0.0005 1.69
aOverlap enrichment of differentially upregulated (log2 fold change of 1.0; adjusted P value of 0.05) and
differentially downregulated (log2 fold change of 1.0; adjusted P value of 0.05) genes for each
possible comparison between RbpAMtbR79A, RbpAMtbR88A, and RbpAMtb72–111 was evaluated by calculating a
hypergeometric P value for fold overenrichment (positive values in the fold enrichment column) or
underenrichment (negative values in the fold enrichment column). Fold enrichment values were calculated
by dividing the number of overlapping genes observed for each comparison by the number of overlapping
genes expected when the null hypothesis of no enrichment was accepted for the same comparison. P
values indicate the probability that the underenrichment or overenrichment in the overlap of differentially
expressed genes of the two strains being compared would occur randomly. P values of 0.05 are
statistically significant.
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Our data indicate that M. tuberculosis has a more stringent requirement for RbpA
activity, similar to what we observed for CarD (5, 13).
We determined that the RbpA SID interaction with  is the only interaction required
for the association of RbpA with the RNAP; the RbpA R88A substitution resulted in not
only loss of the interactions with A and B but also almost complete loss of association
with the core RNAP  subunit. In contrast, deletion of the NTT and CD did not
negatively affect the association of RbpA with RNAP, suggesting that the RbpA NTT and
CD serve functions distinct from interaction with RNAP. The RbpA R88A substitution
also resulted in decreased RbpA protein levels. Previous studies investigating CarD
mutants with altered affinities for the RNAP found that CarD protein levels correlated
with CarD affinity for the RNAP (21). Our data showing that RbpAMtbR88A has a lower
affinity for the RNAP and is present in lower abundance in the cell supports a model in
which RbpA protein levels are also affected by its ability to interact with the RNAP. CarD
was shown to be a target of the Clp protease in M. tuberculosis and, similarly, RbpA
levels were 2-fold higher in a M. tuberculosis strain lacking Clp protease subunits,
suggesting that RbpA protein levels may also be regulated by the Clp protease (24).
Previous studies investigating the effect of RbpA on RPo stability reported that R79
is required for RPo stabilization, whereas both the NTT and CD are dispensable (6, 7). We
have expanded on these findings by determining that the RbpA- interaction is
required for enhanced RPo stability and the NTT and CD antagonize this activity (Fig. 3).
Furthermore, our results suggest that the effect of RbpA on the kinetics of RPo
equilibration can be differentiated from its effect on equilibrium levels of RPo and that
RbpA can affect both forward and reverse rates on the pathway to RPo, at the
concentrations tested. The similar effects of RbpA BL and SID mutations on RPo
stabilization (Fig. 3) mirror the significant overlap in the expression profiles of
RbpAMtbR79A and RbpAMtbR88A (Fig. 4). In contrast, the truncation of NTT and CD, which
affects RPo stability differently than mutations in RbpA BL and CD, results in an
expression profile significantly different from that of RbpAMtbR79A and RbpAMtbR88A.
We have found that RbpAMtbR79A and RbpAMtbR88A mutants can result in both
upregulation and downregulation of transcript levels in M. smegmatis, depending on
the gene. Upregulation of gene expression in RbpA mutants could be due to direct
effects with RbpA acting as a repressor in some promoter contexts, due to differences
in basal initiation kinetics. However, this observation could also be explained by indirect
effects with RbpA enhancing the expression of a transcription factor that represses the
expression of a set of genes. Future studies that expand analysis of RbpA past the
limited promoters that have been explored in vitro will be necessary to address these
possibilities.
Our data from spike-in control qRT-PCR experiments suggest that gene expression
is globally downregulated in the M. smegmatis RbpAMtb72–111 mutant. This suggests
that the NTT and CD are required for efficient gene expression, and it complicates
interpretations of the RbpAMtb72–111 RNA-seq data in this study. This finding may also
have an impact on a previously published RNA-seq data set for the M. smegmatis
RbpAMtb72–111 strain (6). When we compared our RNA-seq data set for RbpAMtb72–111
with the previously reported data, we found that there was no significant overlap in
genes that registered as upregulated or downregulated. This could be due to a
difference in the culturing methods used in the two studies and/or it could be related
to the finding that gene expression in general is less robust. How the NTT and CD
mechanistically promote efficient gene expression while antagonizing RPo stability on
the rrnAP3 promoter in vitro remains an open question for future studies.
MATERIALS AND METHODS
Media and bacterial strains. (i) Mycobacterium tuberculosis. The Erdman strain was grown at 37°C
in 7H9 (broth) or 7H10 (agar) medium supplemented with 60 l/liter oleic acid, 5 g/liter bovine serum
albumin (BSA), 2 g/liter dextrose, and 0.003 g/liter catalase (oleic acid-albumin-dextrose-catalase
[OADC]), 0.5% glycerol, and 0.05% Tween 80 (broth). The M. tuberculosis merodiploid strain was
constructed by integrating pMSG430-rbpAMtbWT (expressing RbpAMtbWT from a constitutive Pmyc1-tetO
promoter; kanamycin resistant) into the attB site of the Erdman strain. A specialized transducing phage
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with homology to M. tuberculosis H37Rv nucleotides 2307223 to 2307826 and 2303122 to 2308681 was
used to replace all except the start and stop codons of the endogenous rbpA gene with a hygromycin
resistance cassette in the merodiploid strain, thus generating ΔrbpA attB::tet-rbpAMtbWT. Gene swapping
was used to construct strains of mycobacteria expressing different rbpA alleles and to test their viability,
as described previously (13, 18). The M. tuberculosis ΔrbpA attB::tet-rbpAMtbWT strain was transformed with
pDB19-rbpAMtbWT (expressing RbpAMtbWT from a constitutive Pmyc1-tetO promoter; zeocin resistant) to
replace the pMSG430-rbpAMtbWT construct at the attB site of the M. tuberculosis ΔrbpA attB::tet-rbpAMtbWT
strain. The transformants were selected with zeocin, and loss of the pMSG430-rbpAMtbWT construct was
confirmed by verifying their inability to grow in the presence of kanamycin. The M. tuberculosis
ΔrbpA::tet-rbpAMtbWT strain transformed with pDB19-rbpAMtbWT was named csm323. Csm323 was trans-
formed with pMSG430-rbpAMtbR79A, pMSG430-rbpAMtbR88A, pMSG430-rbpAMtb1–71, or pMSG430-rbpAMtb72–111
(expressing RbpAMtbR79A, RbpAMtbR88A, RbpAMtb1–71, or RbpAMtb72–111, respectively, from a constitutive
Pmyc-tetO promoter; kanamycin resistant) to replace the pDB19-rbpAMtbWT construct at the attB site of
csm323. The transformants were selected with kanamycin; when positive transformants in M. tuberculosis
csm323 could not be obtained (as was the case for pMSG430-rbpAMtbR79A, pMSG430-rbpAMtbR88A,
pMSG430-rbpAMtb1–71, and pMSG430-rbpAMtb72–111 transformations), the mutations were deemed nonvi-
able.
(ii) Mycobacterium smegmatis. All M. smegmatis strains were derived from mc2155 and grown at
37°C in LB medium supplemented with 0.5% dextrose, 0.5% glycerol, and 0.05% Tween 80 (broth). The
M. smegmatis merodiploid strain was constructed by integrating pMSG430-rbpAMtbWT into the attB site of
mc2155. The M. smegmatis merodiploid strain was transformed with pDB88, with homology to mc2155
nucleotides 3928650 to 3929246 and 3929589 to 3930405, to replace the endogenous rbpA, using
two-step allelic exchange as described previously (25), thus generating ΔrbpA::tet-rbpAMtbWT, which was
named csm275. Csm275 was transformed with pDB19-rbpAMtbWT to replace the pMSG430-rbpAMtbWT
construct at the attB site of the M. smegmatis ΔrbpA attB::tet-rbpAMtbWT strain. The transformants were
selected with zeocin, and loss of the pMSG430-rbpAMtbWT construct was confirmed by verifying their
inability to grow in the presence of kanamycin. The M. smegmatis ΔrbpA::tet-rbpAMtbWT strain transformed
with pDB19-rbpAMtbWT was named csm291. Csm291 was transformed with pMSG430-rbpAMtbWT,
pMSG430-rbpAMtbR79A, pMSG430-rbpAMtbR88A, pMSG430-rbpAMtb1–71, pMSG430-rbpAMtb72–111, pMSG430-
rbpAMtbWT-FLAG, pMSG430-rbpAMtbR79A-FLAG, pMSG430-rbpAMtbR88A-FLAG, pMSG430-rbpAMtb1–71-FLAG, or
pMSG430-rbpAMtb72–111-FLAG to replace the pDB19-rbpAMtbWT construct at the attB site of csm291. Each
FLAG tag repeated the sequence for FLAG twice (2FLAG). The transformants were selected with
kanamycin, and loss of the pDB19-rbpAMtbWT construct was confirmed by verifying their inability to grow
in the presence of zeocin. When positive transformants in csm291 could not be obtained (as was the case
for pMSG430-rbpAMtb1–71 and pMSG430-rbpAMtb1–71-FLAG transformations), the mutations were deemed
nonviable. Csm291 strains transformed with pMSG430-rbpAMtbR79A, pMSG430-rbpAMtbR88A, pMSG430-
rbpAMtb72–111, pMSG430-rbpAMtbWT-FLAG, pMSG430-rbpAMtbR79A-FLAG, pMSG430-rbpAMtbR88A-FLAG, and
pMSG430-rbpAMtb72–111-FLAG were named csm322, csm314, csm328, csm313, csm329, csm327, and
csm347, respectively.
Antibiotics and chemicals. In mycobacterial cultures, 20 g/ml kanamycin and 12.5 g/ml zeocin
were used. In E. coli cultures, 40 g/ml kanamycin, 50 g/ml chloramphenicol, 50 g/ml streptomycin,
and 100 g/ml ampicillin were used.
Western blotting and immunoprecipitation. For immunoprecipitation, 1-liter cultures were pel-
leted by centrifugation, resuspended in 20 ml of 1 phosphate-buffered saline (PBS) with complete
protease inhibitor cocktail (Roche), and lysed with high-pressure (30 lb/in2) cell disruption (CF model;
Constant Systems, Daventry, UK). The lysate was treated with DNase I (New England BioLabs), added to
anti-FLAG affinity gel (clone M2; Sigma-Aldrich, St. Louis, MO), and rotated overnight at 4°C. The
protein-agarose matrix was washed three times with NP-40 buffer (10 mM sodium phosphate [pH 8.0],
150 mM NaCl, 1% Nonidet-40, 1 complete protease inhibitor cocktail). The immunoprecipitated protein
complexes were eluted with 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 150 g/ml FLAG peptide (Sigma-
Aldrich), 1 complete protease inhibitor cocktail. Protein samples were mixed with SDS-PAGE loading
buffer and run on a 4 to 12% Bis-Tris protein gel (Invitrogen). For the Western blot analysis, A and B
were detected using a mouse monoclonal antibody against E. coli 70 (clone 2G10; Neoclone, Madison,
WI), RNAP  was detected using a mouse monoclonal antibody against E. coli RNAP  (clone 8RB13;
Neoclone), and FLAG-tagged RbpA was detected using an anti-FLAG mouse monoclonal antibody
(Sigma-Aldrich). Secondary LiCor IRDye 800CW goat anti-mouse IgG polyclonal antibodies were used to
detect the primary antibodies. Secondary antibody near-infrared fluorescence was detected with the
LiCore Odyssey version 3.0 imaging system, and band intensity was analyzed with Image Studio Lite
version 4.0.
Protein purification for biochemical assays. Plasmids containing the Mycobacterium tuberculosis
H37Rv genomic DNA encoding the different M. tuberculosis RNAP holoenzyme subunits were a gift from
Jayanta Mukhopadhyay (Bose Institute, Kolkata, India) (26, 27). Expression was carried out in accordance
with the method described by Banerjee et al. (26), with minor exceptions. Briefly, E. coli BL21(DE3) cells
were transformed with plasmids pET-Duet-rpoB-rpoC (encoding the  and = subunits), pAcYc-Duet-
sigA-rpoA (encoding an N-terminal 10His-tagged A subunit and  subunit), and pCDF-rpoZ (encoding
the  subunit) and were grown in LB medium at 37°C to an optical density at 600 nm (OD600) of 0.6 to
0.8. The culture was then treated with 0.25 mM isopropyl--D-thiogalactopyranoside (IPTG) and grown
overnight at 16°C. Cells were harvested via centrifugation (4,070  g for 15 min at 4°C), and the resultant
pellets were stored at 80°C. M. tuberculosis RNAP-A holoenzyme was purified according to methods
used previously for the M. bovis RNAP core complex (4). M. tuberculosis RbpA constructs were cloned into
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pET-SUMO (Thermo Fisher Scientific) and transformed into E. coli BL21(DE3). Cultures were grown at 37°C
to an OD600 of 0.8, and protein overexpression was induced with the addition of 0.5 mM IPTG overnight
at 16°C. Cells were harvested by centrifugation (4,070  g for 15 min at 4°C), and the cell pellets were
stored at 80°C. The cells were resuspended in lysis buffer (50 mM NaH2PO4 [pH 8.0], 5 mM imidazole,
300 mM NaCl, 5 mM -mercaptoethanol, protease inhibitor [Sigma-Aldrich]) and lysed by sonication at
4°C. Soluble lysate was separated from insoluble lysate by centrifugation (2,700  g for 20 min at 4°C).
RbpA was purified from the soluble lysate by Ni2 affinity chromatography (Gold Biotechnology). Ni2
columns were washed with wash buffer (50 mM Na2HPO4 [pH 8.0], 20 mM imidazole, 300 mM NaCl) until
no protein was detected with NanoDrop spectrophotometer OD280 readings. RbpA was eluted from the
Ni2 affinity columns with elution buffer (50 mM Na2HPO4 [pH 8.0], 250 mM imidazole, 300 mM NaCl, 5
mM -mercaptoethanol). The His-SUMO tag was cleaved from the RbpA constructs with His-Ulp1
protease during overnight dialysis at 4°C (20 mM Tris-HCl [pH 8.0], 250 mM NaCl, 20 mM imidazole, 1 mM
-mercaptoethanol). The His-SUMO tag and His-Ulp1 were separated from RbpA by a second round of
Ni2 affinity chromatography, and the cleaved RbpA was collected as the flowthrough fraction. Cleaved
RbpA was dialyzed overnight at 4°C in storage buffer (20 mM Tris-HCl [pH 8.0], 250 mM NaCl, 1 mM
-mercaptoethanol), concentrated to approximately 200 M (Vivaspin 20, molecular weight cutoff of
3,000; GE Healthcare), and stored at 80°C.
Preparation of fluorescent promoter DNA template. A Cy3-labeled promoter template of 150 bp
2 nontemplate dT, containing nucleotides 1470151 to 1470300 of the M. tuberculosis Erdman genomic
DNA, including the rrnAP3 promoter, was prepared as described previously (4, 7, 21).
Stopped-flow fluorescence assay. Stopped-flow experiments were performed as described previ-
ously (4, 7, 21), with notable exceptions. Prior to data acquisition, M. tuberculosis RNAP-A holoenzyme,
with or without RbpA protein, was incubated at 37°C for 10 min. All experiments were conducted with
equal-volume mixing of 2 nM Cy3-labeled rrnAP3 promoter DNA with 70 or 200 nM M. tuberculosis
RNAP-A holoenzyme, with or without 4 M RbpA protein. Thus, the final concentrations upon mixing
were 1 nM DNA and 35 or 100 nM RNAP-A holoenzyme, with or without 2 M RbpA protein. Accounting
for all contributions from protein storage buffers, the final reaction buffer conditions upon equal-volume
mixing were as follows: 20 mM Tris (pH 8.0), 77.5 mM NaCl, 10 mM MgCl2, 5 M ZnCl2, 20 M EDTA, 5%
(vol/vol) glycerol, 1 mM dithiothreitol, and 0.1 mg/ml BSA. Experiments were performed with an SX-20
stopped-flow spectrophotometer (Applied Photophysics, Leatherhead, UK) with a dead time of 1 ms
and a total shot volume of 100 l. Samples were excited using a 535-nm fixed-wavelength light-
emitting diode (LED) light source with a 550-nm shortpass filter, and emission was monitored using a
570-nm longpass filter. Data were collected at 37°C for 1,000 s by sampling 5,000 points over a
logarithmic decay. Each protein condition is represented by the average of at least 5 shots obtained
using multiple RNAP preparations, plotted as the fold change over DNA alone according to the formula
(F  Fo)/Fo, where Fo is the buffer-subtracted reading for DNA alone and F is the buffer-subtracted
reading for DNA mixed with protein.
RNA-seq analysis. M. smegmatis strains csm275, csm322, csm314, and csm328 were cultured to an
OD600 of 0.4 to 0.6, pelleted, resuspended in TRIzol (Thermo Fisher Scientific), and lysed by bead beating
(FastPrep; MP Bio, Santa Ana, CA). RNA was extracted with chloroform, precipitated with isopropanol, and
resuspended in water. RNA was treated with DNase I (Thermo Fisher Scientific), and RNA integrity and
quality were analyzed with an Agilent bioanalyzer. rRNA was removed from samples using the Illumina
Ribo-Zero rRNA removal kit. cDNA libraries were generated using an adapted Illumina TruSeq library
preparation kit and were quality controlled by analysis of the cDNA size distribution with the Agilent
TapeStation. cDNA libraries were pooled and sequenced in a single lane of an Illumina HiSeq 2000 Rapid
Run flow cell with a 50-bp single-end read format. Sequencing reads were demultiplexed and converted
to a FASTQ format using Illumina bcl2fastq script. Adapter sequences were trimmed from the raw reads,
which were then aligned with the M. smegmatis mc2155 reference genome (GenBank accession number
NC_008596) using the STAR aligner (28). Sequence alignment map (SAM) files generated from align-
ments were converted to BAM files using SAMTools (29), and aligned reads were counted per genome
feature using the BioConductor package Subread featureCounts function (30). Differential expression
analysis and subsequent PCA were performed with BioConductor DESeq2 (31). Venn diagrams were
made with an online tool (https://www.stefanjol.nl/venny). Hypergeometric P values and enrichment
values were calculated using an online calculator (http://systems.crump.ucla.edu/hypergeometric). The
hypergeometric distribution describes the probability of k successes in s draws, without replacement,
from a population of size N that contains exactly M successes. N was defined at the total number of
differentially expressed genes in the two RbpA mutant constructs being compared, s was defined as the
number of differentially upregulated or downregulated genes in one RbpA mutant included in the
comparison, M was defined as the number of differentially upregulated or downregulated genes in
the second RbpA mutant included in the comparison, and k was defined as the number of differentially
upregulated or downregulated genes shared by the two RbpA mutants in the comparison.
qRT-PCR analysis. M. smegmatis strains csm275, csm322, csm314, and csm328 were cultured to an
OD600 of 0.5 to 0.7, pelleted, resuspended in TRIzol (Thermo Fisher Scientific), and lysed by bead beating
(FastPrep; MP Bio). RNA was extracted with chloroform, precipitated with isopropanol, and resuspended
in water. MS2 bacteriophage RNA (Roche) was added to the bacterial RNA at a ratio of 1 ng of MS2 RNA
per 1 billion bacteria, RNA was treated with DNase I (Thermo Fisher Scientific), and cDNA was synthesized
with the Superscript III first-strand synthesis system (Invitrogen). qRT-PCR was performed with a SYBR
green qPCR kit (Bio-Rad), and MSMEG_0281, MSMEG_5302, MSMEG_1215, MSMEG_3966, MSMEG_3297,
MSMEG_3499, MSMEG_3855, MSMEG_1680, MSMEG_2259, MSMEG_4222, MSMEG_2758, MSMEG_2528,
MSMEG_4497, MSMEG_6466, MSMEG_6947, and MSMEG_2387 transcript levels were measured and
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normalized to spike-in MS2 RNA transcript levels. Primers are listed in Table S3 in the supplemental
material.
Accession number(s). The data discussed in this publication have been deposited in the NCBI Gene
Expression Omnibus (32) and are accessible through GEO Series accession number GSE107123.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/JB
.00690-17.
SUPPLEMENTAL FILE 1, XLSX file, 2.0 MB.
SUPPLEMENTAL FILE 2, XLSX file, 0.1 MB.
SUPPLEMENTAL FILE 3, PDF file, 0.1 MB.
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